Global Mucormycosis Research: A Bibliometric Assessment Based on Scopus Database (1998-2021)
Brij Mohan Gupta1, Ghouse Modin Mamdapur2, Saniya Gupta3, Latika Rohilla3, Devi Dayal3★★ Corresponding author
- 1Formerly with CSIR-National Institute of Science, Technology and Development Studies, New Delhi, INDIA.
- 2Information AND Documentation Division, Synthite Industries (Pvt.) Ltd., Kolenchery, Kerala, INDIA.
- 3Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, INDIA.
CORRESPONDENCE
Devi Dayal
Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, INDIA.
Received: 28-08-2021; Revised: 30-09-2021; Accepted: 04-11-2021.
Volume 13, Issue 4 · pp. 356–362 · PUBLISHED · DOI: 10.5530/jyp.2021.13.89
ABSTRACT
Background:Mucormycosis is an invasive filamentous fungal infection that usually occurs in immunocompromised individuals. Although the disease is well-researched, the assessment of global research on mucormycosis is scarcely reported. Materials and Methods:We used Elsevier’s Scopus database to retrieve mucormycosis publications from 1998 to 2021. Using various bibliometric tools, the publication data were analyzed with regard to the growth in the number of publications, their citations, top-yielding organizations and authors, collaborations, and productive journals. Results:One hundred twenty countries contributed 5658 publications to research on mucormycosis. The USA leads with a 30.6% share, followed by India (14.1%), France, Germany, and Spain (5.4% to 5.8%). The annual and absolute growth was 3.9% and 82.6%; only 11.2% of publications were funded. The average citations per paper decreased from 28.4 to 11.4 during the two 12-yr periods. The research involved 931 organizations and 1123 authors. The leading organizations were the University of Texas, Anderson Cancer Center, USA, PGIMER-Chandigarh, India, and the University of Paris, France, with 154, 150, and 89 publications. Kontoyiannis, Walsh, and Cornely were the most prolific authors contributing 119, 76, and 58 publications. Mycoses, Clinical Infectious Diseases, and Medical Mycology were the most active journals. Conclusion:The quantity of mucormycosis research increased while the quality decreased during 1998-2021. Fostering collaboration between high- and low-income countries may improve the impact of global mucormycosis research.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Gupta, B. M., Mamdapur, G. M., Gupta, S., Rohilla, L., & Dayal, D. (). Global Mucormycosis Research: A Bibliometric Assessment Based on Scopus Database (1998-2021). Journal of Young Pharmacists, 13(4), 356–362. https://doi.org/10.5530/jyp.2021.13.89